The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Production of biopharmaceutical proteins by yeast: Advances through metabolic engineering
Open accessAbstract
Production of recombinant proteins for use as pharmaceuticals, so-called biopharmaceuticals, is a multi-billion dollar industry. Many different cell factories are used for the production of biopharmaceuticals, but the yeast Saccharomyces cerevisiae is an important cell factory as it is used for production of several large volume products. Insulin and insulin analogs are by far the dominating biopharmaceuticals produced by yeast, and this will increase as the global insulin market is expected to grow from USD12B in 2011 to more than USD32B by 2018. Other important biopharmaceuticals produced by yeast are human serum albumin, hepatitis vaccines and virus like particles used for vaccination against human papillomavirus. Here is given a brief overview of biopharmaceutical production by yeast and it is discussed how the secretory pathway can be engineered to ensure more efficient protein production. The involvement of directed metabolic engineering through the integration of tools from genetic engineering, systems biology and mathematical modeling, is also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Construction of Biologically Functional Bacterial Plasmids In Vitro
Cohen, S. N., Chang, A. C. Y., Boyer, H. W., & Helling, R. B. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.11.3240 · Cited by 1,802
Biopharmaceutical benchmarks 2014
Walsh, G. (2014) · Nature Biotechnology · doi:10.1038/nbt.3040 · Cited by 1,008
Patil, C., & Walter, P. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00219-2 · Cited by 780
Biopharmaceutical benchmarks 2010
Walsh, G. (2010) · Nature Biotechnology · doi:10.1038/nbt0910-917 · Cited by 756
Uncovering transcriptional regulation of metabolism by using metabolic network topology
Patil, K. R., & Nielsen, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406811102 · Cited by 646
Self-citationHumanization of yeast to produce complex terminally sialylated glycoproteins
Hamilton, S. R., Davidson, R. C., Sethuraman, N., Nett, J. H., Jiang, Y., Rios, S., Bobrowicz, P., Stadheim, T. A., Li, H., Choi, B.-K., et al. (2006) · Science · doi:10.1126/science.1130256 · Cited by 511
Microbial factories for recombinant pharmaceuticals
Ferrer-Miralles, N., Domingo-Espín, J., Corchero, J. L., Vázquez, E., & Villaverde, A. (2009) · Microbial Cell Factories · doi:10.1186/1475-2859-8-17 · Cited by 465
Optimization of humanized IgGs in glycoengineered Pichia pastoris
Li, H., Sethuraman, N., Stadheim, T. A., Zha, D., Prinz, B., Ballew, N., Bobrowicz, P., Choi, B.-K., Cook, W. J., Cukan, M., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1178 · Cited by 428
The humanization of N-glycosylation pathways in yeast
Wildt, S., & Gerngross, T. U. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1087 · Cited by 393
In silico aided metabolic engineering of Saccharomyces cerevisiae for improved bioethanol production
BRO, C., REGENBERG, B., FORSTER, J., & NIELSEN, J. (2006) · Metabolic Engineering · doi:10.1016/j.ymben.2005.09.007 · Cited by 367
Self-citationNielsen, J. (2001) · Applied Microbiology and Biotechnology · doi:10.1007/s002530000511 · Cited by 314
Self-citationMetabolic engineering of recombinant protein secretion by Saccharomyces cerevisiae
Hou, J., Tyo, K. E. J., Liu, Z., Petranovic, D., & Nielsen, J. (2012) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2012.00810.x · Cited by 211
Self-citationWalsh, G. (2000) · Nature Biotechnology · doi:10.1038/78720 · Cited by 198
A mathematical model of N-linked glycosylation
Krambeck, F. J., & Betenbaugh, M. J. (2005) · Biotechnology and Bioengineering · doi:10.1002/bit.20645 · Cited by 171
Impact of systems biology on metabolic engineering of Saccharomyces cerevisiae
Nielsen, J., & Jewett, M. C. (2008) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2007.00302.x · Cited by 159
Self-citationHigh-level secretion of human growth hormone by Escherichia coli
Chang, C. N., Key, M. L., Bochner, B. R., Heyneker, H. L., & Gray, G. C. (1987) · Gene · doi:10.1016/0378-1119(87)90279-4 · Cited by 148
A mathematical model of N-linked glycoform biosynthesis
Umaña, P., & Bailey, J. E. (1997) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(19970920)55:6<890::aid-bit7>3.0.co;2-b · Cited by 146
Biopharmaceuticals: Biochemistry and Biotechnology
Walsh, G. (1998) · Thammasat University Digital Collections · Cited by 129
Hou, J., Tyo, K. E. J., Liu, Z., Petranović, D., & Nielsen, J. (2012) · Metabolic Engineering · doi:10.1016/j.ymben.2012.01.002 · Cited by 127
Self-citationFifteen years of large scale metabolic modeling of yeast: Developments and impacts
Österlund, T., Nookaew, I., & Nielsen, J. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.07.021 · Cited by 123
Self-citationA systems-level approach for metabolic engineering of yeast cell factories
Kim, I., Roldão, A., Siewers, V., & Nielsen, J. (2011) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2011.00779.x · Cited by 108
Self-citationCan yeast systems biology contribute to the understanding of human disease?
Petranović, D., & Nielsen, J. (2008) · Trends in biotechnology · doi:10.1016/j.tibtech.2008.07.008 · Cited by 107
Self-citationMartínez, J. L., Liu, L., Petranović, D., et al. (2012) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2012.03.011 · Cited by 102
Tyo, K. E. J., Liu, Z., Petranović, D., & Nielsen, J. (2012) · BMC Biology · doi:10.1186/1741-7007-10-16 · Cited by 101
Self-citationToward design-based engineering of industrial microbes
Tyo, K. E. J., Kocharin, K., & Nielsen, J. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.02.001 · Cited by 92
Self-citationWhat's fueling the biotech engine—2010 to 2011
Aggarwal, S. (2011) · Nature Biotechnology · doi:10.1038/nbt.2060 · Cited by 79
Sales of biologics to show robust growth through to 2013
Goodman, M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd3040 · Cited by 77
Engineering eukaryotic protein factories
Schröder, M. (2007) · Biotechnology Letters · doi:10.1007/s10529-007-9524-1 · Cited by 70
Petranović, D., Tyo, K. E. J., Vemuri, G. N., & Nielsen, J. (2010) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2010.00689.x · Cited by 67
Self-citation
Cited by
Tripathi, N. K., & Shrivastava, A. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00420 · Cited by 575
A Review of the Microbial Production of Bioactive Natural Products and Biologics
Pham, J. V., Yilma, M. A., Feliz, A., Majid, M. T., Maffetone, N., Walker, J. R., Kim, E., Cho, H. J., Reynolds, J. M., Song, M. C., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01404 · Cited by 565
Cell factories for insulin production
Baeshen, N. A., Baeshen, M. N., Sheikh, A., Bora, R. S., Ahmed, M. M. M., Ramadan, H. A. I., Saini, K. S., & Redwan, E. M. (2014) · Microbial Cell Factories · doi:10.1186/s12934-014-0141-0 · Cited by 359
Comparison of Yeasts as Hosts for Recombinant Protein Production
Vieira Gomes, A. M., Souza Carmo, T., Silva Carvalho, L., Mendonça Bahia, F., & Parachin, N. S. (2018) · Microorganisms · doi:10.3390/microorganisms6020038 · Cited by 308
Yeast Systems Biology: Model Organism and Cell Factory
Nielsen, J. (2019) · Biotechnology Journal · doi:10.1002/biot.201800421 · Cited by 279
Self-citation
Metadata
- Authors
- Nielsen, J.
- Venue
- Bioengineered
- Publisher
- Informa UK Limited
- Published
- 2013-07
- Volume
- 4
- Issue
- 4
- Pages
- 207-211
- ISSN
- 2165-5979 (ISSN-L)
- 2165-5987
- OpenAlex
- W1487841058
- Cited by
- 270
- References
- 29
- FWCI
- 4.84
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.